tiprankstipranks
Cue Biopharma Inc (CUE)
NASDAQ:CUE
US Market
CUE
Cue Biopharma
RESEARCH TOOLSreports
Want to see CUE full AI Analyst Report?

Cue Biopharma (CUE) Ratios

665 Followers

Cue Biopharma Ratios

CUE's free cash flow for Q2 2026 was $1.00. For the 2026 fiscal year, CUE's free cash flow was decreased by $ and operating cash flow was $-11.13. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Mar 25Mar 24Dec 22
Liquidity Ratios
Current Ratio
 1.25 2.74 1.84 3.01 6.68
Quick Ratio
 1.25 2.74 1.84 3.01 6.68
Cash Ratio
 0.82 2.01 1.64 2.84 4.47
Solvency Ratio
 -5.70 -1.47 -2.61 -1.93 -2.00
Operating Cash Flow Ratio
 -2.36 -1.61 -2.65 -2.34 -3.62
Short-Term Operating Cash Flow Coverage
 0.00 0.00 -8.38 -10.08 -21.30
Net Current Asset Value
$ -1.77M$ 21.20M$ 10.45M$ 27.01M$ 51.59M
Leverage Ratios
Debt-to-Assets Ratio
 0.29 0.10 0.28 0.24 0.21
Debt-to-Equity Ratio
 3.81 0.16 0.51 0.40 0.29
Debt-to-Capital Ratio
 0.79 0.14 0.34 0.28 0.23
Long-Term Debt-to-Capital Ratio
 0.71 0.00 0.00 0.10 0.11
Financial Leverage Ratio
 13.29 1.60 1.84 1.66 1.39
Debt Service Coverage Ratio
 -714.01 -63.77 -7.32 -8.84 -18.86
Interest Coverage Ratio
 -730.70 -74.29 -52.14 -41.89 -74.56
Debt to Market Cap
 0.07 0.00 0.07 0.07 0.10
Interest Debt Per Share
 1.41 1.44 5.15 0.35 0.56
Net Debt to EBITDA
 0.09 1.03 0.36 0.73 0.64
Profitability Margins
Gross Profit Margin
99.69%100.00%100.00%-593.93%100.00%
EBIT Margin
-260.55%-93.73%-429.40%-901.42%-4200.56%
EBITDA Margin
-254.67%-81.06%-404.09%-838.83%-4055.50%
Operating Profit Margin
-261.97%-96.56%-446.86%-949.89%-4275.10%
Pretax Profit Margin
-434.50%-95.03%-437.97%-924.10%-4257.83%
Net Profit Margin
-435.83%-96.85%-437.97%-924.10%-4257.83%
Continuous Operations Profit Margin
-435.83%-96.85%-437.97%-924.10%-4257.83%
Net Income Per EBT
100.31%101.92%100.00%100.00%100.00%
EBT Per EBIT
165.86%98.42%98.01%97.28%99.60%
Return on Assets (ROA)
-534.43%-63.02%-126.35%-82.45%-58.07%
Return on Equity (ROE)
-1032.19%-100.64%-232.44%-136.80%-80.71%
Return on Capital Employed (ROCE)
-1039.56%-92.35%-224.30%-117.32%-66.75%
Return on Invested Capital (ROIC)
-887.33%-86.59%-157.35%-100.71%-62.62%
Return on Tangible Assets
-534.43%-63.02%-126.35%-82.45%-58.07%
Earnings Yield
-84.72%-91.97%-66.25%-42.00%-52.18%
Efficiency Ratios
Receivables Turnover
 5.18 3.69 9.83 3.23 21.84
Payables Turnover
 0.03 0.00 0.00 10.88 0.00
Inventory Turnover
 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
 11.72 6.37 1.92 0.77 0.12
Asset Turnover
 1.23 0.65 0.29 0.09 0.01
Working Capital Turnover Ratio
 3.09 1.57 0.41 0.11 0.02
Cash Conversion Cycle
 -11.82K 98.94 37.14 79.35 16.71
Days of Sales Outstanding
 70.53 98.94 37.14 112.89 16.71
Days of Inventory Outstanding
 0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
 11.89K 0.00 0.00 33.54 0.00
Operating Cycle
 70.53 98.94 37.14 112.89 16.71
Cash Flow Ratios
Operating Cash Flow Per Share
 -7.89 -6.87 -19.35 -0.87 -1.17
Free Cash Flow Per Share
 -7.91 -6.92 -19.38 -0.87 -1.18
CapEx Per Share
 0.02 0.06 0.04 0.00 <0.01
Free Cash Flow to Operating Cash Flow
 1.00 1.01 1.00 1.00 1.00
Dividend Paid and CapEx Coverage Ratio
 -413.60 -122.53 -550.44 0.00 -244.48
Capital Expenditure Coverage Ratio
 -413.60 -122.53 -550.44 0.00 -244.48
Operating Cash Flow Coverage Ratio
 -5.68 -5.17 -4.09 -2.72 -2.16
Operating Cash Flow to Sales Ratio
 -1.33 -0.79 -3.91 -7.28 -33.58
Free Cash Flow Yield
-62.49%-75.59%-59.28%-33.08%-41.32%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -1.13 -1.09 -1.51 -2.38 -1.92
Price-to-Sales (P/S) Ratio
 2.13 1.05 6.61 22.00 81.61
Price-to-Book (P/B) Ratio
 83.86 1.09 3.51 3.26 1.55
Price-to-Free Cash Flow (P/FCF) Ratio
 -1.60 -1.32 -1.69 -3.02 -2.42
Price-to-Operating Cash Flow Ratio
 -3.87 -1.33 -1.69 -3.02 -2.43
Price-to-Earnings Growth (PEG) Ratio
 <0.01 0.02 0.04 0.09 -0.34
Price-to-Fair Value
 83.86 1.09 3.51 3.26 1.55
Enterprise Value Multiple
 -0.75 -0.27 -1.27 -1.89 -1.37
Enterprise Value
 71.70M 5.99M 47.81M 86.97M 69.30M
EV to EBITDA
 -0.75 -0.27 -1.27 -1.89 -1.37
EV to Sales
 1.90 0.22 5.15 15.84 55.66
EV to Free Cash Flow
 -1.43 -0.27 -1.31 -2.18 -1.65
EV to Operating Cash Flow
 -1.43 -0.28 -1.32 -2.18 -1.66
Tangible Book Value Per Share
 0.36 8.37 9.32 0.81 1.84
Shareholders’ Equity Per Share
 0.36 8.37 9.32 0.81 1.84
Tax and Other Ratios
Effective Tax Rate
 >-0.01 -0.02 0.00 0.00 0.00
Revenue Per Share
 5.94 8.70 4.95 0.12 0.03
Net Income Per Share
 -25.88 -8.42 -21.66 -1.11 -1.49
Tax Burden
 1.00 1.02 1.00 1.00 1.00
Interest Burden
 1.67 1.01 1.02 1.03 1.01
Research & Development to Revenue
 2.05 1.37 3.91 7.43 30.99
SG&A to Revenue
 1.57 0.59 1.57 3.04 12.99
Stock-Based Compensation to Revenue
 0.69 0.17 0.74 1.49 7.63
Income Quality
 0.30 0.82 0.89 0.79 0.79
Currency in USD